Clinical Trial: Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905261) titled 'Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma' on Oct. 22.

Brief Summary: This is a Phase I/II clinical study conducted in participants with relapsed/refractory B-Cell Non-Hodgkin Lymphoma. The study aims to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SYS6055 Injection in participants with relapsed/refractory aggressive B-cell lymphoma, and to provide a basis for the recommended dosing regimen in subsequent studies.

Study Start Date: Dec. 15

Study Type: INTERVENTIONAL

Condition: Relapsed/Refractory B-Cell Non-Hodgkin Lym...